Priorities for addressing substance use disorder in humanitarian settings.
Alcohol
Drugs
Humanitarian settings
Substance use
Journal
Conflict and health
ISSN: 1752-1505
Titre abrégé: Confl Health
Pays: England
ID NLM: 101286573
Informations de publication
Date de publication:
23 Sep 2021
23 Sep 2021
Historique:
received:
08
06
2021
accepted:
15
09
2021
entrez:
24
9
2021
pubmed:
25
9
2021
medline:
25
9
2021
Statut:
epublish
Résumé
Populations affected by humanitarian emergencies are vulnerable to substance (alcohol and other drug) use disorders, yet treatment and prevention services are scarce. Delivering substance use disorder treatment services in humanitarian settings is hampered by limited guidance around the preparation, implementation, and evaluation of substance use disorder treatment programs. This study aims to identify and prioritize key gaps and opportunities for addressing substance use disorder in humanitarian settings. UNODC convened a consultation meeting (n = 110) in coordination with UNHCR and WHO and administered an online survey (n = 34) to, thirteen program administrators and policymakers, eleven service providers, nine researchers, and one person with lived experience to explore best practices and challenges to addressing substance use disorder in diverse populations and contexts. Participants presented best practices for addressing substance use disorder, identified and ranked challenges and opportunities for improving the delivery of substance use disorder treatment interventions, and provided recommendations for guidelines that would facilitate the delivery of substance use disorder treatment services in humanitarian emergencies. Participants agreed on key principles for delivering substance use disorder treatment in humanitarian settings that centered on community engagement and building trust, integrated service delivery models, reducing stigma, considering culture and context in service delivery, and an ethical 'do no harm' approach. Specific gaps in knowledge that precluded the delivery of appropriate substance use disorder treatment include limited knowledge of the burden and patterns of substance use in humanitarian settings, the effectiveness of substance use disorder treatment services in humanitarian settings, and strategies for adapting and implementing interventions for a given population and humanitarian context. Participants emphasized the need to strengthen awareness and commitment related to the burden of substance use disorder treatment interventions among communities, practitioners, and policymakers in humanitarian settings. Results from this consultation process highlight existing gaps in knowledge related to the epidemiology and treatment of substance use disorders in humanitarian emergencies. Epidemiological, intervention, and implementation research as well as operational guidance are needed to fill these gaps and improve access to substance use treatment services in humanitarian settings.
Sections du résumé
BACKGROUND
BACKGROUND
Populations affected by humanitarian emergencies are vulnerable to substance (alcohol and other drug) use disorders, yet treatment and prevention services are scarce. Delivering substance use disorder treatment services in humanitarian settings is hampered by limited guidance around the preparation, implementation, and evaluation of substance use disorder treatment programs. This study aims to identify and prioritize key gaps and opportunities for addressing substance use disorder in humanitarian settings.
METHODS
METHODS
UNODC convened a consultation meeting (n = 110) in coordination with UNHCR and WHO and administered an online survey (n = 34) to, thirteen program administrators and policymakers, eleven service providers, nine researchers, and one person with lived experience to explore best practices and challenges to addressing substance use disorder in diverse populations and contexts. Participants presented best practices for addressing substance use disorder, identified and ranked challenges and opportunities for improving the delivery of substance use disorder treatment interventions, and provided recommendations for guidelines that would facilitate the delivery of substance use disorder treatment services in humanitarian emergencies.
RESULTS
RESULTS
Participants agreed on key principles for delivering substance use disorder treatment in humanitarian settings that centered on community engagement and building trust, integrated service delivery models, reducing stigma, considering culture and context in service delivery, and an ethical 'do no harm' approach. Specific gaps in knowledge that precluded the delivery of appropriate substance use disorder treatment include limited knowledge of the burden and patterns of substance use in humanitarian settings, the effectiveness of substance use disorder treatment services in humanitarian settings, and strategies for adapting and implementing interventions for a given population and humanitarian context. Participants emphasized the need to strengthen awareness and commitment related to the burden of substance use disorder treatment interventions among communities, practitioners, and policymakers in humanitarian settings.
CONCLUSIONS
CONCLUSIONS
Results from this consultation process highlight existing gaps in knowledge related to the epidemiology and treatment of substance use disorders in humanitarian emergencies. Epidemiological, intervention, and implementation research as well as operational guidance are needed to fill these gaps and improve access to substance use treatment services in humanitarian settings.
Identifiants
pubmed: 34556142
doi: 10.1186/s13031-021-00407-z
pii: 10.1186/s13031-021-00407-z
pmc: PMC8460183
doi:
Types de publication
Journal Article
Langues
eng
Pagination
71Subventions
Organisme : U.S. Department of State
ID : U.S. Department of State
Informations de copyright
© 2021. The Author(s).
Références
Lancet. 2003 Jun 21;361(9375):2128-30
pubmed: 12826440
PLoS Med. 2011 Sep;8(9):e1001096
pubmed: 21949644
Confl Health. 2011 Feb 11;5(1):1
pubmed: 21310092
Subst Use Misuse. 2017 Sep 19;52(11):1494-1510
pubmed: 28471305
Nature. 2015 Nov 19;527(7578):S172-7
pubmed: 26580324
East Mediterr Health J. 2017 May 01;23(3):231-235
pubmed: 28493271
PLoS One. 2016 Jul 13;11(7):e0159134
pubmed: 27411086
Bull World Health Organ. 2019 Apr 1;97(4):246-246A
pubmed: 30940977
Glob Ment Health (Camb). 2018 Aug 28;5:e28
pubmed: 30202535
J Adv Nurs. 1994 Jan;19(1):180-6
pubmed: 8138622
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
East Mediterr Health J. 2015 Sep 28;21(7):498-502
pubmed: 26442890
BMC Med. 2014 Nov 24;12:228
pubmed: 25420518
Addiction. 2015 Jun;110(6):889-90
pubmed: 25756739
Tob Control. 2016 Mar;25(2):129-40
pubmed: 25770116
Harm Reduct J. 2018 Nov 28;15(1):58
pubmed: 30486840
Confl Health. 2021 Apr 12;15(1):26
pubmed: 33845859
Med Confl Surviv. 2014 Jul-Sep;30(3):182-9
pubmed: 25144954
Subst Use Misuse. 2010 Nov;45(13):2340-55
pubmed: 20469970
Int J Drug Policy. 2012 Sep;23(5):341-5
pubmed: 22717389
BMC Med Ethics. 2016 Apr 29;17(1):25
pubmed: 27129927
Disasters. 2012 Jul;36(3):533-57
pubmed: 22066703
Lancet. 2016 Apr 16;387(10028):1672-85
pubmed: 26454360
BMC Public Health. 2017 Mar 24;17(1):280
pubmed: 28340567
JAMA. 2009 Aug 5;302(5):537-49
pubmed: 19654388
Soc Psychiatry Psychiatr Epidemiol. 2017 Nov;52(11):1425-1434
pubmed: 28321455
Int J Drug Policy. 2016 Jan;27:173-7
pubmed: 26303577
Int J Drug Policy. 2014 Mar;25(2):196-203
pubmed: 24332455
JAMA. 2005 Aug 3;294(5):602-12
pubmed: 16077055
Afr J Psychiatry (Johannesbg). 2009 Aug;12(3):218-22
pubmed: 19750251